Weill Family Foundation Launches $125M Cancer Research Hub to Advance Immunotherapy
The Weill Cancer Hub East, uniting four top institutions, will focus on innovative treatments including tumor microenvironment reprogramming and emerging therapeutics.
- The Weill Family Foundation has donated $50 million, matched by partner institutions, bringing total funding for the new Weill Cancer Hub East to over $125 million.
- The hub will unite Princeton University, The Rockefeller University, Weill Cornell Medicine, and the Ludwig Institute for Cancer Research to advance cancer immunotherapy research.
- Research efforts will focus on reprogramming the tumor microenvironment, exploring the role of nutrition and metabolism, and investigating emerging therapies like GLP-1 agonists.
- A scientific steering committee and leadership committee have been established to guide the hub's research strategy and activities.
- This initiative builds on the foundation's history of funding multidisciplinary biomedical research, including the Weill Neurohub established in 2019.